Furthermore, in vitro studies using various cancer cell types, such as A375, IPC298, SKMEL30, HCT116, MIA, PaCa2, and Panc1, pointed to several additional mutations that cause resistance to ERK inhibitors and favor EMT and tumor progression. The gene discussed is MAPK1; the disease is cancer.